Stay updated on Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial page.

Latest updates to the Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the version history.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe history now shows a new revision entry (v3.4.2) replacing the previous v3.4.1, indicating a minor update to the page revision metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedFooter now shows Revision: v3.4.1 replacing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedGlossary visibility has been added and change highlights are now color-coded (green for additions, red for deletions) on the Study Record History page. The revision label was updated to v3.4.0 and 'No FEAR Act Data' is now displayed.SummaryDifference0.5%

- Check62 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial page.